We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.01B
AUM Growth
-$55.8M
Cap. Flow
-$77.9M
Cap. Flow %
-1.94%
Top 10 Hldgs %
16.78%
Holding
730
New
81
Increased
176
Reduced
283
Closed
57

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
VZ icon
Verizon
VZ
+$26.7M
4
LOW icon
Lowe's Companies
LOW
+$25.6M
5
CMI icon
Cummins
CMI
+$20.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$38.5M
2
CL icon
Colgate-Palmolive
CL
+$31.6M
3
LLY icon
Eli Lilly
LLY
+$30.3M
4
HD icon
Home Depot
HD
+$28.5M
5
MSFT icon
Microsoft
MSFT
+$25.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.88%
2 Technology 13.15%
3 Financials 10.92%
4 Communication Services 10.03%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USMV icon
451
iShares MSCI USA Min Vol Factor ETF
USMV
$23.5B
$485K 0.01%
10,490
-41
-0.4% -$1.82K
GLOB icon
452
Globant
GLOB
$1.57B
$484K 0.01%
+12,300
New +$451K
ACIW icon
453
ACI Worldwide
ACIW
$5.83B
$483K 0.01%
24,741
+140
+0.6% +$2.84K
TVTX icon
454
Travere Therapeutics
TVTX
$5.18B
$480K 0.01%
26,945
+5,185
+24% +$83.9K
SQBG
455
DELISTED
Sequential Brands Group, Inc.
SQBG
$479K 0.01%
1,500
-354
-19% -$99.9K
PPLI
456
People Inc
PPLI
$3.07B
$478K 0.01%
47,494
-7,274
-13% -$67.4K
NE
457
DELISTED
Noble Corporation
NE
$472K 0.01%
57,259
+3,029
+6% +$28.9K
TM icon
458
Toyota
TM
$224B
$468K 0.01%
+4,681
New +$481K
HUM icon
459
Humana
HUM
$43.9B
$467K 0.01%
2,597
-35
-1% -$6.22K
EEM icon
460
iShares MSCI Emerging Markets ETF
EEM
$28.9B
$465K 0.01%
13,538
-1,633
-11% -$54.8K
STZ icon
461
Constellation Brands
STZ
$22.2B
$465K 0.01%
2,812
LAMR icon
462
Lamar Advertising Co
LAMR
$16.2B
$464K 0.01%
6,995
-495
-7% -$31.2K
DD
463
DELISTED
Du Pont De Nemours E I
DD
$457K 0.01%
7,050
-649
-8% -$42.6K
ALGT icon
464
Allegiant Air
ALGT
$2.67B
$455K 0.01%
3,005
+25
+0.8% +$3.86K
WR
465
DELISTED
Westar Energy Inc
WR
$454K 0.01%
8,100
HON icon
466
Honeywell
HON
$77.6B
$453K 0.01%
4,331
-334
-7% -$34.3K
DTE icon
467
DTE Energy
DTE
$29.5B
$449K 0.01%
5,324
GME icon
468
GameStop
GME
$9.77B
$449K 0.01%
67,600
-4,600
-6% -$33.7K
DLR icon
469
Digital Realty Trust
DLR
$70.4B
$442K 0.01%
4,060
+265
+7% +$25.2K
PSA icon
470
Public Storage
PSA
$60.6B
$442K 0.01%
1,730
-3,359
-66% -$862K
IP icon
471
International Paper
IP
$21.8B
$439K 0.01%
10,930
-211
-2% -$8.39K
IBMH
472
DELISTED
iShares iBonds Sep 2019 Term Muni Bond ETF
IBMH
$439K 0.01%
17,055
-160
-0.9% -$4.11K
WCN
473
Waste Connections
WCN
$42.5B
$433K 0.01%
9,020
-150
-2% -$6.83K
AWK icon
474
American Water Works
AWK
$27B
$427K 0.01%
5,050
VALE icon
475
Vale
VALE
$64B
$424K 0.01%
83,800

Similar funds

Boston Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Boston Advisors held 730 positions worth $4.01B, down 1.4% from $4.06B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Advisors's Q2 2016 filing shows 81 new, 176 increased, 283 reduced and 57 closed positions. Its largest new stake was Sherwin-Williams: 204,480 shares worth $20M. The largest sale was AbbVie, an estimated $38.5M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q2 2016 buy was Sherwin-Williams: 204,480 shares worth $20M.
  • Boston Advisors added most to Biogen in Q2 2016, an estimated $32.1M increase.
  • Boston Advisors's biggest Q2 2016 reduction was AbbVie, cutting an estimated $38.5M.
  • Boston Advisors fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $23.4M.
  • Boston Advisors's ten largest holdings make up 17% of its $4.01B portfolio in Q2 2016.
  • Boston Advisors opened 81 new positions and closed 57 in Q2 2016.
  • Boston Advisors's portfolio value fell 1.4% quarter-over-quarter to $4.01B.

Based on Boston Advisors's 13F filing for Q2 2016, filed 26 Jul 2016.